Skip to main content
. 2004 May 4;53(9):809–816. doi: 10.1007/s00262-004-0522-z

Fig. 3.

Fig. 3

IAsys biosensor data for initial slope on one patient. Initial slope (a measure of quantity) shows tenfold increases in both HAMA and polyclonal Ab2 as the patient progresses through the vaccination regimen. Pre pretreatment, V1V6 vaccination boosters, post 1 month post V6. The pretreatment initial slope for Ab2 was unmeasurable by FASTfit software. All points are from single-sample assays